Authors: Caponigro, F Massa, E Manzione, L Rosati, G Biglietto, M De Lucia, L Sguotti, C Sganga, P Avallone, A Comella, P Mantovani, G Comella, G

Citation: F. Caponigro et al., Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG), ANN ONCOL, 12(2), 2001, pp. 199-202

Authors: Comella, P Biglietto, M Casaretti, R De Luica, L Avallone, A Maiorino, L Di Lullo, L De Cataldis, G Rivellini, F Comella, G

Citation: P. Comella et al., Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients - A phase I/II study of the Southern Italy Cooperative Oncology Group, ONCOL-BASEL, 60(2), 2001, pp. 127-133

Authors: Comella, P De Vita, F Mancarella, S De Lucia, L Biglietto, M Casaretti, R Farris, A Ianniello, GP Lorusso, V Avallone, A Carteni, G Leo, S Catalano, G De Lena, M Comella, G

Citation: P. Comella et al., Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II-III randomized trial, ANN ONCOL, 11(10), 2000, pp. 1323-1333

Authors: Sannolo, N Miraglia, N Biglietto, M Acampora, A Malorni, A

Citation: N. Sannolo et al., Determination of cyclophosphamide and ifosphamide in urine at trace levelsby gas chromatography/tandem mass spectrometry, J MASS SPEC, 34(8), 1999, pp. 845-849

Authors: Frasci, G D'Aiuto, G Comella, P Apicella, A Thomas, R Capasso, I Di Bonito, M Carteni, G Biglietto, M Lucia, LD Maiorino, L Piccolo, S Bianchi, U D'Aniello, R Lapenta, L Comella, G

Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group, BREAST CANC, 56(3), 1999, pp. 239-252

Authors: Caponigro, F Comella, P Marcolin, P Spena, FR Biglietto, M Carteni, G De Lucia, L Avallone, A Gravina, A Comella, G

Citation: F. Caponigro et al., A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck, CANCER, 85(4), 1999, pp. 952-959